KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $6.3 million.

  • Medpace Holdings' Share-based Compensation fell 4608.17% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.1 million, marking a year-over-year increase of 4140.78%. This contributed to the annual value of $25.5 million for FY2024, which is 2436.15% up from last year.
  • Latest data reveals that Medpace Holdings reported Share-based Compensation of $6.3 million as of Q3 2025, which was down 4608.17% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Share-based Compensation registered a high of $16.9 million during Q1 2025, and its lowest value of $2.9 million during Q1 2021.
  • Moreover, its 5-year median value for Share-based Compensation was $5.2 million (2023), whereas its average is $5.8 million.
  • Per our database at Business Quant, Medpace Holdings' Share-based Compensation tumbled by 4727.27% in 2021 and then skyrocketed by 29192.58% in 2025.
  • Medpace Holdings' Share-based Compensation (Quarter) stood at $4.0 million in 2021, then surged by 40.49% to $5.6 million in 2022, then fell by 7.65% to $5.2 million in 2023, then rose by 14.02% to $5.9 million in 2024, then grew by 7.37% to $6.3 million in 2025.
  • Its Share-based Compensation was $6.3 million in Q3 2025, compared to $6.0 million in Q2 2025 and $16.9 million in Q1 2025.